Responses
Regular and Young Investigator Award Abstracts
Cell Therapies
409 Manufacturing of a clinical scale CD8 TIL product, AGX148, with and without gene silencing of PD-1 using self-delivering RNAi INTASYLTM PH-762
Compose a Response to This Article
Other responses
No responses have been published for this article.